Pharma or biotech? Save 31% on your ticket with super early-bird pricing + 3-for-2 group packs available. Offer ends in:
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
The next generation of drug product development
and manufacturing technology is here…
Now in it’s 12th year, the 2026 CRBE Summit West returns this February.
Connect with 120+ senior drug development innovators and uncover industry’s latest formulation, product development and delivery technologies for improving performance and manufacuring capabilities.
2026’s Summit covers Innovations in Controlled Release and Bioavailability Enhancement of Small Molecules and Large Biologics Delivery Systems.
✅ 2 full tracks of technical talks, panels and thought-provoking discussion sessions
✅ Network with 100’s of senior development, formulation and manufacturing attendees and solution providers
✅ Multiple exhibits, banquet lunches and dinners, workshops, exhibits, champagne giveaways and networking receptions
✅ Access all sessions post-Summit on-demand so you can relive your best moments
✅ Be part of our community of drug product development experts which will open many doors in the future.
30+
Industry-led Speakers
120+
Senior Attendees
2
Tracked Streams
14+
Networking Hours
18
Solution Providers
2026 Speakers Include
Liangfang Zhang, PhD
Professor, Department of Chemical and Nano Engineering
University of California San Diego
Stephen Buckley, PhD
Vice President, Head of Oral Delivery Technologies
Novo Nordisk
Chong-Hui Gu, PhD
Senior Vice President, Head of CMC
Tenvie Therapeutics
Sasha Ebrahimi, PhD
Senior Principal Scientist, Emerging Drug Delivery Platforms
GlaxoSmithKline
Karthik Nagapudi, PhD
Executive Director & Distinguished Scientist
Genentech
Timothy Day, PhD
Co-Founder & CSO
Particella, Inc.
Yogeshwar Bachhav, PhD
CMC Consultant
AiCuris AG
Julia Rosenberger, PhD
Senior Scientist, Discovery Pharmaceutical Sciences
Merck & Co.
Karunakar Sukuru, PhD
Global Vice President, Pharma Product Development & Head of Scientific Advisory
Catalent Pharma Services
Prajwal Thool, PhD
Scientist III Synthetic Molecule Pharmaceutical Sciences
Genentech
Stephie Lee, PhD
Director, CMC Drug Product and Analytical Development
Boundless Bio
Ruchi Thakkar, PhD
Senior Scientist, Drug Product Development
Bristol Myers Squibb
Dave Miller, PhD
Chief Scientific Officer
AustinPx
Fadi Ibrahim, PhD
Head of USA Drug Product Development and Biopharmaceutics
Sanofi
Elisabeth Kersten, PhD
Formulation Development Lead
Vividion Therapeutics
Shabbir Lobo, PhD
Staff Scientist, Global Innovations and Product Development
Bayer
Tushar Upsunde, PhD
Principal Research Scientist II, Drug Delivery
AbbVie
Ismail Hafez, PhD
Director, Formulation and Delivery Sciences
Ionis Pharmaceuticals
Nick DiFranco, PhD
Senior Marketing Manager, Pharmaceutical Division
Gattefossé USA
Firouz Asgarzadeh, PhD
President of Consulting Services
OSD Pharmaceutical Solutions
Controlled and Modified Release
- Oral Drug Delivery Systems
- Long Acting Injectable Drug Delivery Systems
- Transdermal Drug Delivery Systems
- Modified release coating systems
- Biodegradable and Biocompatible Polymers
- Nanotechnology in Controlled Release
- Pulmonary Drug Delivery Systems
- The Role of Controlled Release in Optimizing Therapeutic Outcomes
- Patient Centric / Pediatric Dose Development
- 3D Printing in Controlled and Modified Release
- Regulatory considerations
- Continuous manufacturing of Controlled and Modified Release products
- Continuous modified release coating systems
- Continuous long-acting microsphere manufacturing
Bioavailability Enhancement
- Formulation strategies for improved absorption of poorly soluble and/or poorly permeable drugs
Solubility and dissolution enhancement techniques:
– Lipid-Based formulations
– Micronization
– Nanomedicine
– Nanocarriers
– Spray Dried Dispersions (SDD)
– Hot Melt Extrusion (HME)
– Kinetisol - Biopharmaceutics classification system (BCS) and its implications
- In vitro-in vivo correlations (IVIVCs)
- Continuous manufacturing technologies for Bioavailability Enhancement
Large Molecule Biologics
- Overcoming Gastrointestinal (GI) Barriers
- Oral delivery of peptides and proteins
- Permeation Enhancers
- Nanoparticle and Microparticle Carriers
- Mucoadhesive and Targeted Delivery Systems
- Formulation Approaches
- Receptor-Mediated Transport
- Novel Delivery Devices
- Stability and Manufacturing Challenges
- Clinical and Regulatory Considerations
- Recent Advances and Future Directions
- Oral delivery of GLP-1 receptor agonists
2026 Sponsors & Exhibitors
Access The Previous Attendee List
Partnering with the 2026 Summit will also help you:
- Enhance commercial relationships with existing clients through platform interaction, meetings, and discussing the latest opportunities
- Raise your brand awareness to a captive and engaging audience, which most-of-all encompasses decision-making criteria
- Elevate your profile amongst industry peers and developing a contact base through 1-2-1 networking sessions
- Generate direct new business opportunities from senior-level attendees with decision-making criteria currently sourcing drug product development solutions
"*" indicates required fields
Registration Pricing:
Super Early-Bird
Register Before Jan 23, 2026
Pharma / Biotech Attendee (Jan Early-bird)
$1100
3-for-2 Group Pack
$2200
CDMO / Vendor Registration
$2500
On-Demand Access
$395
Early-Bird Rate
Register Before Feb 6, 2026
Pharma / Biotech Attendee (Early-bird)
$1400
3-for-2 Group Pack
$2800
CDMO / Vendor Registration
$2500
On-Demand Access
$395
Onsite Pricing
Register Onsite
Pharma / Biotech Standard Rate
$1,600
3-for-2 Group Pack
$3200
CDMO / Vendor Registration
$2500
On-Demand Access
$595
Access the 2025 Summit On-Demand Content for Free
The 2025 Summit highlighted innovative strategies, approaches and platforms designed to overcome drug product development and delivery . From cutting-edge techniques such as electrospinning, mesoporous silica technology, 3D printing, physiochemical optimization, amorphous nanoparticle engineering, to sophisticated pharmacokinetic modeling, the Summit detailed a wide range of approaches. The ultimate objective is to help you save valuable time and resources while expediting the development of your drug products.
"*" indicates required fields